Topic
biotech acquisition
1 stories related to this topic, newest first.
Substrate placeholder — needs reviewscience75 days ago
Gilead Sciences Acquires German Biotech Tubulis for Over $3 Billion
Gilead Sciences announced the acquisition of Tubulis, a German biotechnology company, for more than $3 billion. The deal aims to expand Gilead's oncology drug development pipeline. Tubulis specializes in antibody-drug conjugates for cancer treatments.
ST